Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 54

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 54
---
 that the Investor shall promptly reimburse the Company
for any portion of such payment that a court of competent jurisdiction determines by final and non-appealable judgment that any such Indemnitee
was not entitled to receive hereunder. If any action shall be brought against any Indemnitee in respect of which indemnity may be sought
pursuant to this Agreement, such Indemnitee shall promptly notify the Company in writing, and the Company shall have the right to assume
the defense thereof with counsel of its own choosing reasonably acceptable to the Indemnitee. Any Indemnitee shall have the right to employ
separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the
expense of such Indemnitee, except to the extent that (i) the employment thereof has been specifically authorized by the Company
in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in
such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between the position
of the Company and the position of such Indemnitee, in which case the Company shall be responsible for the reasonable and documented out-of-pocket
fees and expenses of no more than one such separate counsel. Each Indemnitee, as a condition to receiving indemnification as provided
in this Section 9, will cooperate in all reasonable respects with the Company in the defense of any action or claim as to which indemnification
is sought.

10. SUSPENSION EVENTS.

A “”
shall be deemed to have occurred at any time as any of the following events occurs and continues, taking into account any applicable grace
or cure period:

(a) the
effectiveness of a registration statement registering the resale of the Securities lapses for any reason (including, without limitation,
the issuance of a stop order or similar order) or such registration statement (or the prospectus forming a part thereof) is unavailable
to the Investor for resale of any or all of the Securities to be issued to the Investor under the Transaction Documents, and such lapse
or unavailability continues for a period of ten (10) consecutive Business Days or for more than an aggregate of thirty (30) Business Days
in any 365-day period, but excluding a lapse or unavailability where (i) the Company terminates a registration statement after the Investor
has confirmed in writing that